Hikma continues beefing up US and European manufacturing capabilities

Image: iStock/frank600

Hikma invested over $25m in its US facilities in the first half 2016, and plans to use excess capacity at a former Boehringer Ingelheim plant for contract manufacturing.

Image: iStock/CountDuckula

Quality issues at ex-Sun Pharma plant land Frontida with US FDA warning

iStock/RobertHarris000

Grunenthal says anti-crush tech Endo uses for Opana ER helps prevent abuse

iStock/idildemir

API firm Unimark Remedies warned by US FDA about Indian plants

iStock/alice-photo

Pfizer unit Hospira and Napp broke APBI code during Remsima push

See More Headlines

Regulatory & Safety

Biopharma-Reporter was at CPhI Korea at the Coex centre, Seoul

Korea positioned to be global biopharma powerhouse, says industry association

iStock/andrewsafonov

Sagent recalls second lot of antibiotic made by Astral SteriTech after rust found in vial

iStock/preechatoy

Actavis pulls Patheon-made diabetes pills after out-of-spec tests

See More in Regulatory & Safety

Ingredients

iStock/AlexRaths

Pfizer to buy AstraZeneca's antibiotic business in deal worth up to $1.5bn

iStock/Zaharia_Bogdan

Phyton has developed a cell-based thapsigargin production method for Inspyr

Siegfried's St Vulbas site in France - acquired from BASF last year (source Siegfried)

BASF API biz boosts Siegfried in H1, but IT integration costs hit profits

See More in Ingredients

Drug Delivery

Image: iStock/pichet_w

Public Patheon's $2bn warchest may bolster biologics offering, analyst

iStock/AlonsoAguilar

US FDA changes policy on switching hard gel capsule suppliers

Image: iStock/Alkov

Antibiotic resistance most imminent threat to humanity, says bacteriophage maker

See More in Drug Delivery

Processing

Seoul, Korea iStock/Sean Pavone

Korea opportunities: A look at drug and biologic manufacturing in the land of morning calm

iStock/s-c-s

Cost pressures turning pharma towards automation tech, says Zenith

The Melrose Park, Il facility will undergo $250 of investment over the next decade. Image: Google Streetview

Fresenius Kabi set for tax breaks after commiting to invest $250m in US plant

See More in Processing

Popular News

iStock/artJazz

UK MHRA strips Pfizer-owned India antibiotics plant of GMP certificate

iStock/sigurcamp

Pfizer vancomycin supplier Zhejiang Medicine warned by US FDA

iStock/AlonsoAguilar

US FDA changes policy on switching hard gel capsule suppliers

Galleries

Videos

Audio

Latest Products

See more products